• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肺量计检测执行中的可变性及其对初级保健中 COPD 治疗的影响。

Variability in the performing of spirometry and its consequences in the treatment of COPD in primary care.

机构信息

Área científica IDIAP Jordi Gol, Barcelona, España.

出版信息

Arch Bronconeumol. 2011 May;47(5):226-33. doi: 10.1016/j.arbres.2010.10.009. Epub 2011 Feb 4.

DOI:10.1016/j.arbres.2010.10.009
PMID:21295903
Abstract

BACKGROUND

Several studies have approached the use of spirometry in the treatment of chronic obstructive pulmonary disease (COPD) in Primary Care (PC), but few have analysed its impact on the treatment of the patient with COPD.

OBJECTIVES

To evaluate the use of spirometry in the diagnosis and follow-up of COPD patients in PC, and its impact on treatment. To analyse the variation in the performing of spirometry between PC centres.

METHODOLOGY

A multicentre, observational and cross-sectional study of COPD patients seen in PC in Catalonia (Spain) during 2004-2005. A multilevel logistic regression model was used to identify factors associated with having spirometry and to determine the variation between the different centres.

RESULTS

Twenty-one centres which included 801 patients took part. Only 53.2% of them had a diagnostic spirometer available and the mean (standard deviation) FEV1(%) was 54.8% (18%). The registers of smoking habits, complementary tests and spirometry follow-up were more common among patients who had a diagnostic spirometry available compared to those who did not. No statistically significant differences were found as regards demographic, clinical, treatment and quality of life variables between patients with and without follow-up spirometry. Significant variation was observed in the percentage of diagnostic spirometries between different PC centres (variance=0.217; p<0.001).

CONCLUSION

Spirometry is underused in PC and performing it during follow-up is not associated to the different treatments received, or with a more complete approach to the disease. There is significant variation in the performing of spirometry among PC centres.

摘要

背景

多项研究探讨了在基层医疗保健(PC)中使用肺量计来治疗慢性阻塞性肺疾病(COPD),但很少有研究分析其对 COPD 患者治疗的影响。

目的

评估肺量计在 PC 中 COPD 患者的诊断和随访中的使用情况及其对治疗的影响。分析 PC 中心之间肺量计检测的差异。

方法

这是一项在 2004-2005 年期间在西班牙加泰罗尼亚地区的 PC 中观察 COPD 患者的多中心、观察性、横断面研究。采用多水平逻辑回归模型来确定与进行肺量计检测相关的因素,并确定不同中心之间的差异。

结果

有 21 个中心参与了研究,共纳入 801 名患者。仅有 53.2%的中心配备有诊断性肺量计,平均(标准差)FEV1(%)为 54.8%(18%)。与没有诊断性肺量计的患者相比,有诊断性肺量计的患者的吸烟习惯、补充检查和肺量计随访记录更为常见。在患者的人口统计学、临床、治疗和生活质量变量方面,有无随访肺量计的患者之间未发现统计学差异。不同 PC 中心之间的诊断性肺量计检测百分比存在显著差异(方差=0.217;p<0.001)。

结论

肺量计在 PC 中的使用不足,在随访中进行肺量计检测与所接受的不同治疗或更全面的疾病管理方法无关。PC 中心之间在进行肺量计检测方面存在显著差异。

相似文献

1
Variability in the performing of spirometry and its consequences in the treatment of COPD in primary care.肺量计检测执行中的可变性及其对初级保健中 COPD 治疗的影响。
Arch Bronconeumol. 2011 May;47(5):226-33. doi: 10.1016/j.arbres.2010.10.009. Epub 2011 Feb 4.
2
Quality of forced spirometry in primary care, impact on the COPD treatment.基层医疗中用力肺活量测定的质量,对慢性阻塞性肺疾病治疗的影响。
Arch Bronconeumol. 2011 May;47(5):224-5. doi: 10.1016/j.arbres.2011.03.001. Epub 2011 Apr 12.
3
[Quality of life with chronic obstructive pulmonary disease: the influence of level of patient care].[慢性阻塞性肺疾病患者的生活质量:患者护理水平的影响]
Arch Bronconeumol. 2004 Oct;40(10):431-7.
4
COPD health care in Sweden - A study in primary and secondary care.瑞典的 COPD 医疗保健 - 初级和二级保健的研究。
Respir Med. 2010 Mar;104(3):404-11. doi: 10.1016/j.rmed.2009.10.007. Epub 2009 Dec 5.
5
How often is diagnosis of COPD confirmed with spirometry?COPD 的诊断有多少次是通过肺功能检查( spirometry )来确认的?
Respir Med. 2010 Apr;104(4):550-6. doi: 10.1016/j.rmed.2009.10.023.
6
The efficacy of incentive spirometry in patients with COPD.激励性肺量计对慢性阻塞性肺疾病患者的疗效。
Respirology. 2005 Jun;10(3):349-53. doi: 10.1111/j.1440-1843.2005.00716.x.
7
Acute exacerbation of chronic obstructive pulmonary disease in primary care setting in Spain: the EPOCAP study.西班牙基层医疗保健中慢性阻塞性肺疾病的急性加重:EPOCAP 研究。
Ther Adv Respir Dis. 2010 Aug;4(4):215-23. doi: 10.1177/1753465810374611. Epub 2010 Jul 12.
8
Spirometry for detection of undiagnosed chronic obstructive pulmonary disease in primary care.在基层医疗中使用肺量测定法筛查未诊断的慢性阻塞性肺疾病。
Eur J Gen Pract. 2010 Dec;16(4):215-21. doi: 10.3109/13814788.2010.518233. Epub 2010 Sep 19.
9
COPD case finding by spirometry in high-risk customers of urban community pharmacies: a pilot study.城市社区药店高危顾客的肺量计 COPD 病例发现:一项试点研究。
Respir Med. 2009 Jun;103(6):839-45. doi: 10.1016/j.rmed.2008.12.022. Epub 2009 Feb 5.
10
Under-diagnosis of chronic obstructive pulmonary disease: a qualitative study in primary care.慢性阻塞性肺疾病的漏诊:一项初级保健中的定性研究
Respir Med. 2008 May;102(5):738-43. doi: 10.1016/j.rmed.2007.12.008. Epub 2008 Jan 28.

引用本文的文献

1
FEV1/FEV6 Cutoff Points to Avoid False Negatives When Using Portable Devices, PICO-6 and COPD-6, in COPD Detection in Primary Healthcare Services.在基层医疗服务中使用便携式设备PICO-6和COPD-6进行慢性阻塞性肺疾病(COPD)检测时,避免假阴性的第一秒用力呼气容积(FEV1)/用力呼气6秒容积(FEV6)截断点
J Clin Med. 2025 Jan 17;14(2):576. doi: 10.3390/jcm14020576.
2
Walking or breathing: comparing the 6-minute walking distance test to the pulmonary function test for lung resection candidates.步行还是呼吸:比较6分钟步行距离测试与肺功能测试对肺切除候选者的适用性
J Cardiovasc Thorac Res. 2024;16(2):97-101. doi: 10.34172/jcvtr.31816. Epub 2024 Jun 25.
3
Validity of the Espiro Mobile Application in the Interpretation of Spirometric Patterns: An App Accuracy Study.
Espiro移动应用程序在解读肺量计模式中的有效性:一项应用程序准确性研究。
Diagnostics (Basel). 2023 Dec 22;14(1):29. doi: 10.3390/diagnostics14010029.
4
Ever Smoking is Not Associated with Performed Spirometry while Occupational Exposure and Respiratory Symptoms are.经常吸烟与进行肺功能检查无关,而职业暴露和呼吸道症状有关。
Int J Chron Obstruct Pulmon Dis. 2023 Mar 17;18:341-348. doi: 10.2147/COPD.S394832. eCollection 2023.
5
Deep learning for spirometry quality assurance with spirometric indices and curves.深度学习在肺量计质量保证中的应用,涉及肺量计指数和曲线。
Respir Res. 2022 Apr 21;23(1):98. doi: 10.1186/s12931-022-02014-9.
6
Economic Impact of Low Adherence to COPD Management Guidelines in Spain.西班牙低遵从 COPD 管理指南的经济影响。
Int J Chron Obstruct Pulmon Dis. 2021 Nov 16;16:3131-3143. doi: 10.2147/COPD.S322793. eCollection 2021.
7
Clinical characteristics and factors associated with triple therapy use in newly diagnosed patients with COPD.COPD 初诊患者三联治疗应用的临床特征及相关因素。
NPJ Prim Care Respir Med. 2021 Mar 22;31(1):16. doi: 10.1038/s41533-021-00227-x.
8
Population-based study of LAMA monotherapy effectiveness compared with LABA/LAMA as initial treatment for COPD in primary care.基于人群的研究:与 LABA/LAMA 初始治疗相比,LAMA 单药治疗在初级保健中对 COPD 的疗效。
NPJ Prim Care Respir Med. 2018 Sep 28;28(1):36. doi: 10.1038/s41533-018-0102-x.
9
Improvement in the management of chronic obstructive pulmonary disease following a clinical educational program: results from a prospective cohort study in the Sicilian general practice setting.临床教育项目对慢性阻塞性肺疾病管理的改善:西西里普通实践环境中前瞻性队列研究的结果。
NPJ Prim Care Respir Med. 2018 Mar 23;28(1):10. doi: 10.1038/s41533-018-0077-7.
10
Characteristics of COPD patients initiating treatment with aclidinium or tiotropium in primary care in Catalonia: a population-based study.加泰罗尼亚初级保健中开始使用阿地溴铵或噻托溴铵治疗的慢性阻塞性肺疾病患者的特征:一项基于人群的研究。
Int J Chron Obstruct Pulmon Dis. 2017 Apr 12;12:1145-1152. doi: 10.2147/COPD.S131016. eCollection 2017.